Why Agios Pharmaceuticals Stock Zoomed to a 13% Gain on Wednesday [Globe and Mail, The (Toronto, Canada)]
Agios Pharmaceuticals, Inc. (AGIO)
Last agios pharmaceuticals, inc. earnings: 4/30 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.agios.com/investor-overview
Company Research
Source: Globe and Mail, The
Agios Pharmaceutical s (NASDAQ: AGIO) was a standout stock in the healthcare sector on Hump Day. Investors eagerly snapped up the company's shares after it unveiled its latest quarterly earnings report and business update. Agios closed the midweek trading session up by more than 13% as a result. A mighty molecule Agios' revenue-generating molecule is mitapivat, which earned its second Food and Drug Administration (FDA) approval -- under the brand name Aqvesme -- last December. It's a drug indicated for the treatment of anemia in adult patients with alpha or beta-thalassemia (a condition in which the body produces insufficient or abnormal hemoglobin). Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Image source: Getty Images. Between Aqvesme and Pyrukynd, a mitapivat drug that earned an FDA green light for
Show less
Read more
Impact Snapshot
Event Time:
AGIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AGIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AGIO alerts
High impacting Agios Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AGIO
News
- Why Agios Pharmaceuticals Stock Zoomed to a 13% Gain on Wednesday [Yahoo! Finance]Yahoo! Finance
- Agios Reports First Quarter 2026 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- Agios Pharmaceuticals Q1 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Agios Reports First Quarter 2026 Financial Results and Provides Business UpdateGlobeNewswire
- BofA Reaffirms Buy Rating for Agios Pharmaceuticals (AGIO) [Yahoo! Finance]Yahoo! Finance
AGIO
Earnings
- 4/29/26 - Beat
AGIO
Sec Filings
- 4/29/26 - Form SCHEDULE
- 4/29/26 - Form 10-Q
- 4/29/26 - Form 8-K
- AGIO's page on the SEC website